195 related articles for article (PubMed ID: 24657655)
1. RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.
Boregowda RK; Olabisi OO; Abushahba W; Jeong BS; Haenssen KK; Chen W; Chekmareva M; Lasfar A; Foran DJ; Goydos JS; Cohen-Solal KA
Cancer Lett; 2014 Jun; 348(1-2):61-70. PubMed ID: 24657655
[TBL] [Abstract][Full Text] [Related]
2. BEL β-Trefoil Reduces the Migration Ability of RUNX2 Expressing Melanoma Cells in Xenotransplanted Zebrafish.
Valenti MT; Marchetto G; Perduca M; Tiso N; Mottes M; Dalle Carbonare L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168858
[TBL] [Abstract][Full Text] [Related]
3. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
4. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
5. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
6. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma.
Cecconi D; Brandi J; Manfredi M; Serena M; Dalle Carbonare L; Deiana M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Avanzi F; Antoniazzi F; Marengo E; Tiso N; Mottes M; Zipeto D; Valenti MT
Sci Rep; 2019 May; 9(1):8052. PubMed ID: 31142788
[TBL] [Abstract][Full Text] [Related]
7. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
[TBL] [Abstract][Full Text] [Related]
8. Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity.
Underwood KF; D'Souza DR; Mochin-Peters M; Pierce AD; Kommineni S; Choe M; Bennett J; Gnatt A; Habtemariam B; MacKerell AD; Passaniti A
J Bone Miner Res; 2012 Apr; 27(4):913-25. PubMed ID: 22189971
[TBL] [Abstract][Full Text] [Related]
9. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
[TBL] [Abstract][Full Text] [Related]
10. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C
Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674
[TBL] [Abstract][Full Text] [Related]
11. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE
PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma.
Riminucci M; Corsi A; Peris K; Fisher LW; Chimenti S; Bianco P
Calcif Tissue Int; 2003 Sep; 73(3):281-9. PubMed ID: 14667142
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential cation 3 channel regulates melanoma proliferation and migration.
Oda K; Umemura M; Nakakaji R; Tanaka R; Sato I; Nagasako A; Oyamada C; Baljinnyam E; Katsumata M; Xie LH; Narikawa M; Yamaguchi Y; Akimoto T; Ohtake M; Fujita T; Yokoyama U; Iwatsubo K; Aihara M; Ishikawa Y
J Physiol Sci; 2017 Jul; 67(4):497-505. PubMed ID: 27613608
[TBL] [Abstract][Full Text] [Related]
15. GLI2-mediated melanoma invasion and metastasis.
Alexaki VI; Javelaud D; Van Kempen LC; Mohammad KS; Dennler S; Luciani F; Hoek KS; Juàrez P; Goydos JS; Fournier PJ; Sibon C; Bertolotto C; Verrecchia F; Saule S; Delmas V; Ballotti R; Larue L; Saiag P; Guise TA; Mauviel A
J Natl Cancer Inst; 2010 Aug; 102(15):1148-59. PubMed ID: 20660365
[TBL] [Abstract][Full Text] [Related]
16. The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma.
Iizuka S; Abdullah C; Buschman MD; Diaz B; Courtneidge SA
Oncotarget; 2016 Nov; 7(48):78473-78486. PubMed ID: 27802184
[TBL] [Abstract][Full Text] [Related]
17. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
Wang Q; Yu W; Huang T; Zhu Y; Huang C
Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
[TBL] [Abstract][Full Text] [Related]
18. Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.
Mizuhashi S; Fukushima S; Ishibashi T; Kuriyama H; Kimura T; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Kita K; Ihn H
J Dermatol Sci; 2021 Apr; 102(1):16-24. PubMed ID: 33583643
[TBL] [Abstract][Full Text] [Related]
19. CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration.
Braig S; Wallner S; Junglas B; Fuchshofer R; Bosserhoff AK
Br J Cancer; 2011 Jul; 105(2):231-8. PubMed ID: 21673687
[TBL] [Abstract][Full Text] [Related]
20. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.
Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P
PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
